|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Engelke M, Mills K, Seitz S, et al:
Characterization of a hepatitis B and hepatitis delta virus
receptor binding site. Hepatology. 43:750–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ye L, Dong N, Wang Q, et al: Progressive
changes in hepatoma cells stably transfected with hepatitis B virus
X gene. Intervirology. 51:50–58. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Artavanis-Tsakonas S: The molecular
biology of the Notch locus and the fine tuning of differentiation
in Drosophila. Trends Genet. 4:95–100. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leong KG and Karsan A: Recent insights
into the role of Notch signaling in tumorigenesis. Blood.
107:2223–2233. 2006. View Article : Google Scholar
|
|
6
|
Gridley T: Notch signaling and inherited
disease syndromes. Hum Mol Genet. 12(Spec1): R9–R13. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kopan R and Ilagan MX: The canonical Notch
signaling pathway: unfolding the activation mechanism. Cell.
137:216–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koch U and Radtke F: Notch signaling in
solid tumors. Curr Top Dev Biol. 92:411–455. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ellisen LW, Bird J, West DC, et al: TAN-1,
the human homolog of the Drosophila notch gene, is broken by
chromosomal translocations in T lymphoblastic neoplasms. Cell.
66:649–661. 1991.PubMed/NCBI
|
|
10
|
Allen TD, Rodriguez EM, Jones KD, et al:
Activated Notch1 induces lung adenomas in mice and cooperates with
Myc in the generation of lung adenocarcinoma. Cancer Res.
71:6010–6018. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Cui Y, Gao G, et al: Notch1 is an
independent prognostic factor for patients with glioma. J Surg
Oncol. 103:813–817. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Li B, Ji ZZ, et al: Notch1
regulates the growth of human colon cancers. Cancer. 116:5207–5218.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zardawi SJ, Zardawi I, McNeil CM, et al:
High Notch1 protein expression is an early event in breast cancer
development and is associated with the HER-2 molecular subtype.
Histopathology. 56:286–296. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bin Hafeez B, Adhami VM, Asim M, et al:
Targeted knockdown of Notch1 inhibits invasion of human prostate
cancer cells concomitant with inhibition of matrix
metalloproteinase-9 and urokinase plasminogen activator. Clin
Cancer Res. 15:452–459. 2009.
|
|
15
|
Sjolund J, Johansson M, Manna S, et al:
Suppression of renal cell carcinoma growth by inhibition of Notch
signaling in vitro and in vivo. J Clin Invest. 118:217–228. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Balint K, Xiao M, Pinnix CC, et al:
Activation of Notch1 signaling is required for
beta-catenin-mediated human primary melanoma progression. J Clin
Invest. 115:3166–3176. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu XM, Phan T, Patel PN, et al: Chrysin
activates Notch1 signaling and suppresses tumor growth of
anaplastic thyroid carcinoma in vitro and in vivo. Cancer.
119:774–781. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jonusiene V, Sasnauskiene A, Lachej N, et
al: Down-regulated expression of Notch signaling molecules in human
endometrial cancer. Med Oncol. 30:4382013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qi R, An H, Yu Y, et al: Notch1 signaling
inhibits growth of human hepatocellular carcinoma through induction
of cell cycle arrest and apoptosis. Cancer Res. 63:8323–8329.
2003.PubMed/NCBI
|
|
20
|
Viatour P, Ehmer U, Saddic LA, et al:
Notch signaling inhibits hepatocellular carcinoma following
inactivation of the RB pathway. J Exp Med. 208:1963–1976. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Giovannini C, Gramantieri L, Chieco P, et
al: Selective ablation of Notch3 in HCC enhances doxorubicin’s
death promoting effect by a p53-dependent mechanism. J Hepatol.
50:969–979. 2009.PubMed/NCBI
|
|
22
|
Wang F, Zhou H, Xia X, et al: Activated
Notch signaling is required for hepatitis B virus X protein to
promote proliferation and survival of human hepatic cells. Cancer
Lett. 298:64–73. 2010. View Article : Google Scholar
|
|
23
|
Cheng B, Zheng Y, Guo X, et al: Hepatitis
B viral X protein alters the biological features and expressions of
DNA repair enzymes in LO2 cells. Liver Int. 30:319–326. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo J, Zhou H, Wang F, et al: The
hepatitis B virus X protein downregulates NF-κB signaling pathways
through decreasing the Notch signaling pathway in HBx-transformed
L02 cells. Int J Oncol. 42:1636–1643. 2013.PubMed/NCBI
|
|
25
|
Wang F, Zhou H, Yang Y, et al: Hepatitis B
virus X protein promotes the growth of hepatocellular carcinoma by
modulation of the Notch signaling pathway. Oncol Rep. 27:1170–1176.
2012.PubMed/NCBI
|
|
26
|
Gao J, Dong Y, Zhang B, et al: Notch1
activation contributes to tumor cell growth and proliferation in
human hepatocellular carcinoma HepG2 and SMMC7721 cells. Int J
Oncol. 41:1773–1781. 2012.PubMed/NCBI
|
|
27
|
Lim SO, Park YM, Kim HS, et al: Notch1
differentially regulates oncogenesis by wildtype p53 overexpression
and p53 mutation in grade III hepatocellular carcinoma. Hepatology.
53:1352–1362. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou L, Wang DS, Li QJ, et al: The
down-regulation of Notch1 inhibits the invasion and migration of
hepatocellular carcinoma cells by inactivating the
cyclooxygenase-2/Snail/E-cadherin pathway in vitro. Dig Dis Sci.
58:1016–1025. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Greenbaum LE: Cell cycle regulation and
hepatocarcinogenesis. Cancer Biol Ther. 3:1200–1207. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu JW, Lin YM, Chang JG, et al: Clinical
implications of deregulated CDK4 and Cyclin D1 expression in
patients with human hepatocellular carcinoma. Med Oncol.
30:3792013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pok S, Wen V, Shackel N, et al: Cyclin E
facilitates dysplastic hepatocytes to bypass G/S checkpoint in
hepatocarcinogenesis. J Gastroenterol Hepatol. 28:1545–1554. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tait SW and Green DR: Mitochondria and
cell death: outer membrane permeabilization and beyond. Nat Rev Mol
Cell Biol. 11:621–632. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Riedl SJ and Shi Y: Molecular mechanisms
of caspase regulation during apoptosis. Nat Rev Mol Cell Biol.
5:897–907. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Plati J, Bucur O and Khosravi-Far R:
Apoptotic cell signaling in cancer progression and therapy. Integr
Biol. 3:279–296. 2011. View Article : Google Scholar : PubMed/NCBI
|
